TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Amicus Shares Barely Budge on Prediction of $3 Billion Buyout
STOCKS

The Nominees for Best Biopharma CEO of 2015 Are...

JPMorgan’s Top 4 Oversold Pharma Stocks for Patient Investors
OPINION

Jim Cramer -- Valeant's Sales Struggles Mean Allergan Could Profit

Pfizer's Poor Earnings Feed the Allergan Tie-Up Fire
MERGERS AND ACQUISITIONS

Pfizer's Bid for Allergan May Be Too Good to Turn Down

Allergan Just Can't Break Through Despite a Ton of Positive Catalysts at Its Back
INVESTING

Allergan Beats Earnings, Delays Forecast Until Next Quarter

Allergan Beats Estimates, Company to Update Guidance Next Quarter
VIDEO

Allergan Beats Estimates, Company to Update Guidance Next Quarter

Where Donald Trump Is Spending His Campaign Funds (Hint: His Bodyguard Really Likes McDonald’s)
INVESTING

What to Watch Thursday -- Trump, Bush, Allergan Earnings, Jobless Claims

Univar to Buy Nexeo for $2 Billion
OPINION

10 Best Biotech Stocks in the NASDAQ

Jim Cramer's Top Takeaways: The Rubicon Project, GameStop, Delta Air Lines, Alcoa
OPINION

Jim Cramer's Top Takeaways: BioMarin, Radius Health, Allergan, Diageo, Wayfair

Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Here's Why We Had a Rally Today

Jim Cramer's Top Takeaways: Luxoft, Nordstrom, Domino's, Honeywell
OPINION

Jim Cramer's Top Takeaways: Palo Alto Networks, Tesla, Ambarella, Allergan, Wingstop, Alkermes

Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Thanks for Nothing, Janet Yellen

February 27 Premarket Briefing: 10 Things You Should Know
MARKETS

Stocks Climb as Fed Meeting Suggests 2015 Hikes

J.C. Penney Announces Leadership Changes, Stock Edges Higher
OPINION

5 Stocks on Traders' Radars -- and What You Should Do With Them

Stock Markets Grind Higher as Apple Gains on Watch Sales
MARKETS

Stocks Recover; Yellen Sees Residual Weakness in Labor Market

Stocks Fluctuate as Oil Pares Losses, Greek Talks Continue
MARKETS

Crude Oil Boosts Stocks as Domestic Inventories Fall

Allergan Just Can't Break Through Despite a Ton of Positive Catalysts at Its Back
OPINION

Jim Cramer -- Let's Face It, Allergan's Kythera Acquisition Is 'Brilliant'

NewLink Genetics (NLNK) Upgraded From Sell to Hold
MARKETS

Kythera Biopharma (KYTH) Stock Soaring; Jim Cramer Calls Allergan Deal 'Brilliant'

Stocks Are Slightly Lower as First-Quarter GDP, Chicago PMI Decline
MARKETS

Stock Futures Are Mixed as Investors Await Fed Announcement

Jim Cramer Says PepsiCo (PEP) is Best Consumer Packaged Goods Company in the World
MARKETS

Allergan (AGN) Stock May Trade Higher; Jim Cramer Calls Kythera Acquisition 'Brilliant'

'Mad Money' Lightning Round: Take Intuit Over H&R Block
JIM CRAMER

'Mad Money' Lightning Round: DreamWorks Animation Is Dead Money

Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: There Was Good News Out There Today

Exact Sciences in Talks to Buy Genomic Health - Report
OPINION

Jim Cramer -- Kythera Biopharmaceuticals Is Proving the Bears Wrong

'Mad Money' Lightning Round: Energy Transfer Partners Is Going Higher
JIM CRAMER

'Mad Money' Lightning Round: Sell, Sell, Sell Protein Design Labs

Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Snap Judgments Will Cost You

Inovio Stock Rises on Positive Results From Ebola Vaccine Tests
INVESTING

Kythera CEO Sees Big Profits in Double Chins